# v4.13

## Related releases

## Data changes
### Gene
```
EMSY Gene Summary Updated
EMSY Gene Background Updated
FGF23 Gene Summary Updated
FGF23 Gene Background Updated
FRS2 Gene Summary Updated
FRS2 Gene Background Updated
GABRA6 Gene Background Updated
GABRA6 Gene Summary Updated
GATA4 Gene Summary Updated
GATA4 Gene Background Updated
KEL Gene Summary Updated
KEL Gene Background Updated
PIK3C2B Gene Summary Updated
PIK3C2B Gene Background Updated
PRKDC Gene Summary Updated
PRKDC Gene Background Updated
QKI Gene Summary Updated
QKI Gene Background Updated
RANBP2 Gene Summary Updated
RANBP2 Gene Background Updated
SOX10 Gene Summary Updated
SOX10 Gene Background Updated
STAT4 Gene Summary Updated
STAT4 Gene Background Updated
TAF1 Gene Summary Updated
TAF1 Gene Background Updated
```

### Alteration
```
ABL1 M237V Added
ABL1 I242T Added
ABL1 K247R Added
ABL1 L248R Added
ABL1 Q252R Added
ABL1 E258D Added
ABL1 E275K Added
ABL1 L273M Added
ABL1 E275Q Added
ABL1 V280A Added
ABL1 T277A Added
ABL1 F311V Added
ABL1 L298V Added
ABL1 I293V Added
ABL1 E355D Added
ABL1 A344V Added
ABL1 G250V Added
ABL1 A380T Added
ABL1 G514S Added
ABL1 E453K Added
ABL1 E453V Added
ABL1 M472I Added
ABL1 E453G Added
ALK T1151R, Mutation Effect Description Updated
ARAF Q349_F351delinsL Added
BRAF R509H, Mutation Effect Updated
	 New: Likely Loss-of-function
	 Old: Loss-of-function
BRCA1 S316G Added
BRCA1 C64R Added
BRCA1 L246V, Mutation Effect Description Updated
BRCA2 L1539S Added
BTK M437R, Oncogenicity Updated
	 New: Likely
	 Old: Inconclusive
BTK V416L, Oncogenicity Updated
BTK L528W, Oncogenicity Updated
EGFR G465E, Oncogenicity Updated
EGFR V441D Added
EGFR G465E, Mutation Effect Description Updated
EGFR V441G Added
EGFR S492R, Oncogenicity Updated
	 Old: Yes
EMSY Gene Type Updated
EMSY Amplification Added
FGF23 Gene Type Updated
FGF23 Amplification Added
FRS2 Gene Type Updated
FRS2 Amplification Added
GABRA6 Gene Type Updated
GATA4 Gene Type Updated
GATA4 Deletion Added
GATA4 Truncating Mutations Added
KEL Gene Type Updated
KEL Amplification Added
NRAS Y64D Added
NRAS E153K Added
PIK3C2B Gene Type Updated
PIK3C2B Amplification Added
PRKDC Gene Type Updated
PRKDC Amplification Added
PRKDC Deletion Added
PRKDC Truncating Mutations Added
QKI Gene Type Updated
QKI Truncating Mutations Added
QKI Deletion Added
RANBP2 Gene Type Updated
RANBP2 Amplification Added
ROS1 GOPC-ROS1 Fusion, Mutation Effect Description Updated
RRAS G38V Added
SOX10 Gene Type Updated
STAT4 Gene Type Updated
STAT4 Amplification Added
TAF1 Gene Type Updated
TAF1 Amplification Added
```

### Evidence
```
ALK Fusions, Non-Small Cell Lung Cancer, Alectinib  Updated
BRCA1 Oncogenic Mutations, Breast Cancer, Talazoparib  Updated
BRCA1 Oncogenic Mutations, Breast Cancer, Olaparib  Updated
BRCA2 Oncogenic Mutations, Breast Cancer, Talazoparib  Updated
BRCA2 Oncogenic Mutations, Breast Cancer, Olaparib  Updated
CDK4 Amplification, Dedifferentiated Liposarcoma, Well-Differentiated Liposarcoma, Palbociclib, Abemaciclib  Updated
EGFR S464L, Colorectal Cancer, Cetuximab, Panitumumab R2 Deleted
EGFR S492R, Colorectal Cancer Added
EGFR S464L, Colorectal Cancer, Cetuximab, Panitumumab R2 Added
EGFR G465R, Colorectal Cancer Added
EGFR G465E, Colorectal Cancer Added
ERBB2 Amplification, Breast Cancer, Ado-Trastuzumab Emtansine  Updated
ERBB2 Amplification, Breast Cancer, Trastuzumab Deruxtecan  Updated
ERBB2 Amplification, Esophagogastric Cancer, Pembrolizumab + Trastuzumab + Chemotherapy  Updated
ESR1 D538, E380, Y537, L536, L469V, S463P (Oncogenic ligand-binding domain missense mutations), Breast Cancer, Elacestrant  Updated
FGFR1 Oncogenic Mutations, All Solid Tumors, Erdafitinib, AZD4547  Updated
FGFR2 Oncogenic Mutations, All Solid Tumors, Erdafitinib, AZD4547  Updated
FGFR3 Fusions, Bladder Cancer, Erdafitinib  Updated
FGFR3 R248C, S249C, G370C, Y373C, Bladder Cancer, Erdafitinib  Updated
FGFR3 Oncogenic Mutations, All Solid Tumors, Erdafitinib, AZD4547  Updated
RET Fusions, All Solid Tumors {excluding Non-Small Cell Lung Cancer, Thyroid Cancer}, Selpercatinib  Updated
TSC1 Oncogenic Mutations, Encapsulated Glioma, Everolimus  Updated
TSC2 Oncogenic Mutations, Encapsulated Glioma, Everolimus  Updated
```

